Wealth Enhancement Advisory Services, LLC Adaptive Biotechnologies Corp Transaction History
Wealth Enhancement Advisory Services, LLC
- $55.6 Billion
- Q2 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 11,576 shares of ADPT stock, worth $135,323. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,576
Previous 11,746
1.45%
Holding current value
$135,323
Previous $87,000
54.02%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ADPT
# of Institutions
251Shares Held
151MCall Options Held
44.3KPut Options Held
47.8K-
Viking Global Investors LP30MShares$351 Million0.74% of portfolio
-
Rubric Capital Management LP New York, NY13.1MShares$153 Million2.79% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$136 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.1MShares$130 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN6.64MShares$77.7 Million0.01% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $1.67B
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...